by Siddhi Camila Lama, Ph.D. | Aug 28, 2023 | Finasteride, Hair Restoration Treatments
Finasteride is the only pill that’s FDA-approved to treat androgenetic alopecia. It works as a hormone blocker, reducing levels of dihydrotestosterone (DHT) in the body. Lowering DHT levels is important since this androgen is the primary hormonal component involved in...
by Siddhi Camila Lama, Ph.D. | Aug 18, 2023 | Hair Restoration Treatments, Light Therapy
Sciton, the producer of a fractional ablative and non-ablative hybrid laser known as HALO®, has just launched a pilot study. They’ll be testing the use of the non-ablative function of their HALO® laser (1470 nm) as a treatment for male and female...
by Ann-Marie D’Arcy-Sharpe | Aug 8, 2023 | Hair Restoration Treatments, PEMF (Pulsed Electromagnetic Field Therapy)
The latest pattern hair loss clinical trial to be announced this year is a laser hair therapy study being conducted by StimuSIL, a European-American start-up. This study is testing the safety and effectiveness of a novel, patented laser and microneedling device on men...
by Maha Rehman | Jul 31, 2023 | Hair Restoration Treatments, Microneedling
Microneedling — also known as collagen induction therapy — is a minimally invasive cosmetic procedure that helps rejuvenate your skin and also increase your hair growth. (1) This regenerative technique can be done as part of DIY self-care at home, or...
by Siddhi Camila Lama, Ph.D. | Jul 19, 2023 | Hair Restoration Treatments
Kintor Pharmaceutical Ltd. recently announced the US phase II clinical trial results for its androgen receptor antagonist, pyrilutamide. This topical androgen receptor-blocking drug, also known as KX-826, is being developed for the treatment of male and female...
by Siddhi Camila Lama, Ph.D. | Jul 10, 2023 | Hair Restoration Treatments
Cosmo Pharmaceuticals recently announced the start of two multicenter phase 3 clinical trials for its higher-strength version of clascoterone, an androgen receptor inhibitor they’ve named Breezula®. This topical androgen receptor-blocking drug started...